Prime Medicine Common Etf Price Patterns
| PRME Etf | USD 3.30 0.02 0.60% |
Momentum 45
Impartial
Oversold | Overbought |
EPS Estimate Next Quarter (0.20) | EPS Estimate Current Year (1.27) | EPS Estimate Next Year (0.90) | Wall Street Target Price 6.4643 | EPS Estimate Current Quarter (0.25) |
Using Prime Medicine hype-based prediction, you can estimate the value of Prime Medicine Common from the perspective of Prime Medicine response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Prime Medicine using Prime Medicine's stock options and short interest. It helps to benchmark the overall future attitude of investors towards Prime using crowd psychology based on the activity and movement of Prime Medicine's stock price.
Prime Medicine Implied Volatility | 1.97 |
Prime Medicine's implied volatility exposes the market's sentiment of Prime Medicine Common stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Prime Medicine's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Prime Medicine stock will not fluctuate a lot when Prime Medicine's options are near their expiration.
The fear of missing out, i.e., FOMO, can cause potential investors in Prime Medicine to buy its etf at a price that has no basis in reality. In that case, they are not buying Prime because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell etfs at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Prime Medicine after-hype prediction price | USD 3.28 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as etf price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Prediction based on Rule 16 of the current Prime contract
Based on the Rule 16, the options market is currently suggesting that Prime Medicine Common will have an average daily up or down price movement of about 0.12% per day over the life of the 2026-04-17 option contract. With Prime Medicine trading at USD 3.3, that is roughly USD 0.004063 . If you think that the market is fully incorporating Prime Medicine's daily price movement you should consider acquiring Prime Medicine Common options at the current volatility level of 1.97%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Check out Prime Medicine Basic Forecasting Models to cross-verify your projections. Prime Medicine After-Hype Price Density Analysis
As far as predicting the price of Prime Medicine at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Prime Medicine or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Etf prices, such as prices of Prime Medicine, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Prime Medicine Estimiated After-Hype Price Volatility
In the context of predicting Prime Medicine's etf value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Prime Medicine's historical news coverage. Prime Medicine's after-hype downside and upside margins for the prediction period are 0.16 and 8.47, respectively. We have considered Prime Medicine's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Prime Medicine is risky at this time. Analysis and calculation of next after-hype price of Prime Medicine Common is based on 3 months time horizon.
Prime Medicine Etf Price Outlook Analysis
Have you ever been surprised when a price of a ETF such as Prime Medicine is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Prime Medicine backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Etf price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Prime Medicine, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.11 | 5.19 | 0.03 | 0.01 | 9 Events / Month | 5 Events / Month | In about 9 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
3.30 | 3.28 | 0.61 |
|
Prime Medicine Hype Timeline
Prime Medicine Common is at this time traded for 3.30. The entity has historical hype elasticity of -0.03, and average elasticity to hype of competition of 0.01. Prime is expected to decline in value after the next headline, with the price expected to drop to 3.28. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -0.61%, whereas the daily expected return is at this time at -0.11%. The volatility of related hype on Prime Medicine is about 5138.61%, with the expected price after the next announcement by competition of 3.31. About 18.0% of the company outstanding shares are owned by corporate insiders. The book value of Prime Medicine was at this time reported as 0.92. The company recorded a loss per share of 1.42. Given the investment horizon of 90 days the next expected press release will be in about 9 days. Check out Prime Medicine Basic Forecasting Models to cross-verify your projections.Prime Medicine Related Hype Analysis
Having access to credible news sources related to Prime Medicine's direct competition is more important than ever and may enhance your ability to predict Prime Medicine's future price movements. Getting to know how Prime Medicine's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Prime Medicine may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| AMRN | Amarin PLC | (0.69) | 9 per month | 0.00 | (0.04) | 4.89 | (3.95) | 21.26 | |
| ALT | Altimmune | 0.20 | 9 per month | 5.16 | 0.03 | 9.80 | (6.22) | 33.75 | |
| KRRO | Frequency Therapeutics | 0.08 | 6 per month | 0.00 | (0.03) | 10.98 | (6.05) | 79.86 | |
| DBVT | DBV Technologies | 0.59 | 11 per month | 4.12 | 0.12 | 10.53 | (6.81) | 36.36 | |
| LRMR | Larimar Therapeutics | (0.08) | 7 per month | 0.00 | (0.04) | 6.96 | (7.16) | 20.14 | |
| CLLS | Cellectis SA | (0.12) | 8 per month | 4.71 | 0.03 | 8.64 | (7.69) | 29.31 | |
| ANNX | Annexon | 0.31 | 8 per month | 3.51 | 0.15 | 11.30 | (6.79) | 35.10 | |
| ANRO | Alto Neuroscience | 0.99 | 5 per month | 5.44 | 0.09 | 7.87 | (8.77) | 26.04 | |
| ACIU | AC Immune | (0.12) | 7 per month | 0.00 | (0.03) | 7.01 | (8.36) | 26.05 | |
| SLN | Silence Therapeutics PLC | (0.15) | 7 per month | 0.00 | (0.12) | 6.88 | (5.89) | 23.80 |
Prime Medicine Additional Predictive Modules
Most predictive techniques to examine Prime price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Prime using various technical indicators. When you analyze Prime charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Prime Medicine Predictive Indicators
The successful prediction of Prime Medicine stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Prime Medicine Common, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Prime Medicine based on analysis of Prime Medicine hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Prime Medicine's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Prime Medicine's related companies.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Prime Etf
Prime Medicine financial ratios help investors to determine whether Prime Etf is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Prime with respect to the benefits of owning Prime Medicine security.